Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation

You-Jung Choi1,2, Bongseong Kim3, Tae-Min Rhee2,4

  • 1Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital & Korea University College of Medicine, Seoul, Korea.

Scientific Reports
|September 22, 2022
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) patients without atrial fibrillation (AF) face a higher risk of ischemic stroke (IS). This risk is particularly elevated in older individuals and those with heart failure, highlighting a critical need for proactive management.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Atrial fibrillation (AF) is a known risk factor for ischemic stroke (IS) in hypertrophic cardiomyopathy (HCM).
  • The risk of IS in HCM patients without documented AF is less understood.
  • This study addresses the underrecognized risk of IS in HCM patients without AF.

Purpose of the Study:

  • To investigate the incidence and risk factors of IS in HCM patients without documented AF.
  • To compare the risk of IS in HCM patients without AF to a matched control group.
  • To identify specific subgroups within the HCM population at higher risk for IS.

Main Methods:

  • Nationwide population-based cohort study using the Korean National Health Insurance database.
  • Included 8,328 HCM patients without documented AF and 16,656 matched non-HCM controls (2010-2016).
  • Propensity score matching was used to control for confounding factors; primary outcome was incident IS.

Main Results:

  • The incidence of IS was significantly higher in the HCM group (3.9%) compared to controls (2.7%).
  • Overall IS incidence was 0.72/100 person-years in HCM patients versus 0.44/100 person-years in controls (HR 1.64).
  • Age ≥ 65 years (aHR 2.74) and chronic heart failure (aHR 1.75) were independent risk factors for IS in HCM patients without AF.

Conclusions:

  • HCM patients without documented AF have an elevated risk of IS.
  • Older age (≥ 65 years) and co-existing chronic heart failure significantly increase IS risk in this population.
  • These findings emphasize the importance of risk stratification and management for IS in HCM patients, even in the absence of AF.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21